| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 107.35B | 97.85B | 112.90B | 120.80B | 101.12B |
| Gross Profit | 29.95B | 24.81B | 28.74B | 31.09B | 25.93B |
| EBITDA | 16.05B | 13.32B | 16.83B | 19.34B | 16.51B |
| Net Income | 8.66B | 5.64B | 10.48B | 11.41B | 9.02B |
Balance Sheet | |||||
| Total Assets | 166.37B | 145.63B | 150.69B | 143.87B | 128.67B |
| Cash, Cash Equivalents and Short-Term Investments | 28.72B | 28.90B | 26.69B | 20.55B | 18.78B |
| Total Debt | 5.99B | 7.28B | 14.53B | 20.15B | 20.25B |
| Total Liabilities | 38.51B | 32.28B | 40.31B | 50.65B | 48.01B |
| Stockholders Equity | 127.86B | 113.35B | 110.36B | 93.21B | 80.65B |
Cash Flow | |||||
| Free Cash Flow | 9.36B | 13.12B | 15.72B | 5.08B | 4.96B |
| Operating Cash Flow | 10.83B | 15.79B | 21.45B | 8.26B | 8.23B |
| Investing Cash Flow | -7.66B | -3.73B | -6.47B | -4.42B | -4.83B |
| Financing Cash Flow | -4.92B | -9.69B | -10.67B | -2.67B | -622.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥256.38B | 13.32 | ― | 1.53% | 9.71% | 54.82% | |
76 Outperform | ¥1.88T | 7.87 | 12.05% | 1.50% | 9.27% | 3.50% | |
75 Outperform | ¥12.76T | 22.92 | 9.29% | 1.19% | 6.76% | 27.25% | |
72 Outperform | ¥52.12B | 12.37 | ― | 0.91% | 8.50% | 14.99% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥52.52B | -60.12 | ― | 5.01% | -25.54% | -166.77% | |
58 Neutral | ¥1.44T | 36.88 | 8.39% | 1.49% | 0.83% | -37.84% |